rewirebio.iobenchmarks
Model

Enchant v3

Enchant v3 is Iambic's multimodal transformer for drug discovery. It predicts molecular properties and preclinical and clinical endpoints from structures, sequences, omics, assay data, text and images, and Iambic uses it to choose compounds and prioritise experiments.

Sources (2)Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report); Iambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-report: introduction and 'Ingest diverse data'; enchant-v3-20261102-source-release: subtitle and highlights

No reviewed evaluations are linked here in this release. See the sources below.

Overview

limited source coverage · Automated source review, 2026-11-02. All specifications and missing details

Model Deployment Profile

Enchant v3 has no ranked result on a use-case protocol in this release.

Recorded parameters: 41 billion. Licence: Not recorded.

Model Capabilities & Hardware Requirements

Deployment facts recorded for Enchant v3. Fields the record does not carry are marked not recorded.

Parameters41 billion
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessProprietary. Iambic deploys it internally and with…
LicenseNot recorded

Evaluated Checkpoint: Enchant v3 (announced 21 September 2026)

Use this model

How it works, versions and access

How it works

How it works

A mixture-of-experts transformer trained jointly on many data types and endpoints, so that data on one endpoint or molecule informs predictions for related ones. Each prediction carries an uncertainty estimate, which Iambic uses to decide which experiments to run. The model is fine-tuned each week on new laboratory data.

SourcesEnchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report) · enchant-v3-20261102-source-report: 'Leverage model scale', 'Convert model outputs into probability-guided decisions', 'How Enchant impacts discovery at Iambic', 'Enchant v3: Achieving scalable predictability'
Versions

Enchant v1 (2024) had 1 billion parameters and Enchant v2 (2025) 7 billion. Enchant v3 has 41 billion. New in v3: inverse design, omics-based and image-based prediction, and peptides. Results and access terms of v1 or v2 do not carry over to v3. NeuralPLexer is a separate Iambic model for protein-ligand structure.

Sources (2)Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report); Iambic platform page · enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'; enchant-v3-20261102-source-platform: platform description
Strengths, limitations and unresolved questions

Strengths and limitations

Limitations and conditions

Profile review details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Stable record: enchant-v3-20261102-model-enchant-v3

Specifications

Inputs, training, access and other details

Explanatory profile: limited source coverage · Automated source review, 2026-11-02. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.

Inputs, outputs and configuration
PropertyDescription and evidence
Parameters41 billion
Sources (2)Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report); Iambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'; enchant-v3-20261102-source-release: highlights
ArchitectureMultimodal mixture-of-experts transformer
SourcesEnchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report) · enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'
Pretraining4.5 trillion tokens
SourcesIambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-release: highlights
Prediction targetsMore than 6,000 molecular properties
SourcesIambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-release: subtitle and highlights
Input modalities16, including text, assay data, molecule, protein and 3D structure, images, multi-omics, biologics, clinical trial data and pharmacokinetics
SourcesIambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-release: highlights
Training dataPublic, proprietary and partner data; not itemised · Not reported in inspected sources
Sources (2)Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report); Iambic launches Enchant v3 (Iambic press release) · enchant-v3-20261102-source-report: 'Expand therapeutic opportunity'; enchant-v3-20261102-source-release: 'Ingest diverse data'
Weights, API and licenceNone located; Iambic describes internal and partner deployment · Source unavailable
Sources (2)Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report); Iambic platform page · enchant-v3-20261102-source-report: 'Enchant drives an engine for new medicines'; enchant-v3-20261102-source-platform: platform description
OutputsNot extracted or verified for this record.
Known versionsNot extracted or verified for this record.
Context limitsNot extracted or verified for this record.
AccessNot extracted or verified for this record.
Code licenceNot extracted or verified for this record.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

22 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Parameters
41 billion
Individual claims
Iambic launches Enchant v3 (Iambic press release)

Original source ↗

enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'; enchant-v3-20261102-source-release: highlights

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Press release dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.0.value

Source artifact SHA-256: 1c0424831dc79abd3be4024ad0d54d45c2d0c6d7425370f32dfa43e27e63a90f

Hash scope: Hash scope not separately documented; inspect source record

Parameters
41 billion
Individual claims
Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report)

Original source ↗

enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'; enchant-v3-20261102-source-release: highlights

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Web page dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.0.value

Source artifact SHA-256: 045f05652d2f8986fbf509ea32eda93fc4ec7d7f94e5ebf6bc0aa76b243fa3d8

Hash scope: Hash scope not separately documented; inspect source record

Architecture
Multimodal mixture-of-experts transformer
Individual claims
Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report)

Original source ↗

enchant-v3-20261102-source-report: 'Enchant v3: Achieving scalable predictability'

Version: Web page dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.1.value

Source artifact SHA-256: 045f05652d2f8986fbf509ea32eda93fc4ec7d7f94e5ebf6bc0aa76b243fa3d8

Hash scope: Hash scope not separately documented; inspect source record

Pretraining
4.5 trillion tokens
Individual claims
Iambic launches Enchant v3 (Iambic press release)

Original source ↗

enchant-v3-20261102-source-release: highlights

Version: Press release dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.2.value

Source artifact SHA-256: 1c0424831dc79abd3be4024ad0d54d45c2d0c6d7425370f32dfa43e27e63a90f

Hash scope: Hash scope not separately documented; inspect source record

Prediction targets
More than 6,000 molecular properties
Individual claims
Iambic launches Enchant v3 (Iambic press release)

Original source ↗

enchant-v3-20261102-source-release: subtitle and highlights

Version: Press release dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.3.value

Source artifact SHA-256: 1c0424831dc79abd3be4024ad0d54d45c2d0c6d7425370f32dfa43e27e63a90f

Hash scope: Hash scope not separately documented; inspect source record

Input modalities
16, including text, assay data, molecule, protein and 3D structure, images, multi-omics, biologics, clinical trial data and pharmacokinetics
Individual claims
Iambic launches Enchant v3 (Iambic press release)

Original source ↗

enchant-v3-20261102-source-release: highlights

Version: Press release dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

source checked

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.4.value

Source artifact SHA-256: 1c0424831dc79abd3be4024ad0d54d45c2d0c6d7425370f32dfa43e27e63a90f

Hash scope: Hash scope not separately documented; inspect source record

Training data
Public, proprietary and partner data; not itemised
Individual claims
Iambic launches Enchant v3 (Iambic press release)

Original source ↗

enchant-v3-20261102-source-report: 'Expand therapeutic opportunity'; enchant-v3-20261102-source-release: 'Ingest diverse data'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Press release dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

unreported

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.5.value

Source artifact SHA-256: 1c0424831dc79abd3be4024ad0d54d45c2d0c6d7425370f32dfa43e27e63a90f

Hash scope: Hash scope not separately documented; inspect source record

Training data
Public, proprietary and partner data; not itemised
Individual claims
Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report)

Original source ↗

enchant-v3-20261102-source-report: 'Expand therapeutic opportunity'; enchant-v3-20261102-source-release: 'Ingest diverse data'

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Web page dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

unreported

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.5.value

Source artifact SHA-256: 045f05652d2f8986fbf509ea32eda93fc4ec7d7f94e5ebf6bc0aa76b243fa3d8

Hash scope: Hash scope not separately documented; inspect source record

Weights, API and licence
None located; Iambic describes internal and partner deployment
Individual claims
Iambic platform page

Original source ↗

enchant-v3-20261102-source-report: 'Enchant drives an engine for new medicines'; enchant-v3-20261102-source-platform: platform description

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Web page as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

unavailable

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.6.value

Source artifact SHA-256: c555311e25c43f5d88c6345757045dd73d9cf22779f856713963e85af47b1e6e

Hash scope: Hash scope not separately documented; inspect source record

Weights, API and licence
None located; Iambic describes internal and partner deployment
Individual claims
Enchant v3: Molecular superintelligence for end-to-end drug R&D (Iambic report)

Original source ↗

enchant-v3-20261102-source-report: 'Enchant drives an engine for new medicines'; enchant-v3-20261102-source-platform: platform description

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Web page dated 21 September 2026, as served on 2026-11-02
Retrieved: 2026-11-02T10:47:00Z

unavailable

automated source review · 2026-11-02

Audit details

Checked against the three pinned Iambic pages; build.py asserts each quoted figure. See docs/reviews/2026-11-02-enchant-v3.md.

Field: attributes.profile.facts.6.value

Source artifact SHA-256: 045f05652d2f8986fbf509ea32eda93fc4ec7d7f94e5ebf6bc0aa76b243fa3d8

Hash scope: Hash scope not separately documented; inspect source record

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: discovered

3 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID enchant-v3-20261102-model-enchant-v3.

Source locator: enchant-v3-20261102-source-report: whole report; enchant-v3-20261102-source-release: highlights; enchant-v3-20261102-source-platform: platform description

Related records

    How to cite

    Enchant v3. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/model/enchant-v3-20261102-model-enchant-v3/

    Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

    The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

    Suggest a correction